Abstract
ACAD9 (acyl-CoA dehydrogenase 9) is an essential factor for the mitochondrial respiratory chain complex I assembly. ACAD9, a member of acyl-CoA dehydrogenase family, has high homology with VLCAD (very long-chain acyl-CoA dehydrogenase) and harbors a homodimer structure. Recently, patients with ACAD9 deficiency have been described with a wide clinical spectrum ranging from severe lethal form to moderate form with exercise intolerance.
We report here a prenatal presentation with intrauterine growth retardation and cardiomegaly, with a fatal outcome shortly after birth. Compound heterozygous mutations, a splice-site mutation – c.1030-1G>T and a missense mutation – c.1249C>T; p.Arg417Cys, were identified in the ACAD9 gene. Their effect on protein structure and expression level was investigated. Protein modeling suggested a functional effect of the c.1030-1G>T mutation generating a non-degraded truncated protein and the p.Arg417Cys, creating an aberrant dimer. Our results underscore the crucial role of ACAD9 protein for cardiac function.
Competing interests: None declared
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Assouline Z, Jambou M, Rio M et al (2012) A constant and similar assembly defect of mitochondrial respiratory chain complex I allows rapid identification of NDUFS4 mutations in patients with Leigh syndrome. Biochim Biophys Acta 1822:1062–1069
Chen VB, Arendall WB 3rd, Headd JJ et al (2010) MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr D Biol Crystallogr 66:12–21
Davis IW, Leaver-Fay A, Chen VB et al (2007) MolProbity: all-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res 35:W375–W383
Efremov RG, Baradaran R, Sazanov LA (2010) The architecture of respiratory complex I. Nature 465:441–445
Ensenauer R, He M, Willard JM et al (2005) Human acyl-CoA dehydrogenase-9 plays a novel role in the mitochondrial beta-oxidation of unsaturated fatty acids. J Biol Chem 280:32309–32316
Fu R, Ceballos-Picot I, Torres RJ et al (2014) Genotype-phenotype correlations in neurogenetics: Lesch–Nyhan disease as a model disorder. Brain 137:1282–1303
Gerards M, van den Bosch BJ, Danhauser K et al (2011) Riboflavin-responsive oxidative phosphorylation complex I deficiency caused by defective ACAD9: new function for an old gene. Brain 134:210–219
Guex N, Peitsch MC (1997) SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 18:2714–2723
Haack TB, Danhauser K, Haberberger B et al (2010) Exome sequencing identifies ACAD9 mutations as a cause of complex I deficiency. Nat Genet 42:1131–1134
He M, Rutledge SL, Kelly DR et al (2007) A new genetic disorder in mitochondrial fatty acid beta-oxidation: ACAD9 deficiency. Am J Hum Genet 81:87–103
Henriques BJ, Olsen RK, Bross P, Gomes CM (2010) Emerging roles for riboflavin in functional rescue of mitochondrial beta-oxidation flavoenzymes. Curr Med Chem 17:3842–3854
Kelley LA, Sternberg MJ (2009) Protein structure prediction on the Web: a case study using the Phyre server. Nat Protoc 4:363–371
Kraulis PJ (1991) MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J Appl Crystallogr 24:946–950
Mimaki M, Wang X, McKenzie M, Thorburn DR, Ryan MT (2012) Understanding mitochondrial complex I assembly in health and disease. Biochim Biophys Acta 1817:851–862
Nouws J, Nijtmans L, Houten SM et al (2010) Acyl-CoA dehydrogenase 9 is required for the biogenesis of oxidative phosphorylation complex I. Cell Metab 12:283–294
Nouws J, Nijtmans LG, Smeitink JA, Vogel RO (2012) Assembly factors as a new class of disease genes for mitochondrial complex I deficiency: cause, pathology and treatment options. Brain 135:12–22
Nouws J, Te Brinke H, Nijtmans LG, Houten SM (2014a) ACAD9, a complex I assembly factor with a moonlighting function in fatty acid oxidation deficiencies. Hum Mol Genet 23:1311–1319
Nouws J, Wibrand F, van den Brand M et al (2014b) A patient with complex I deficiency caused by a novel ACAD9 mutation not responding to riboflavin treatment. JIMD Rep 12:37–45
Oey NA, den Boer ME, Wijburg FA et al (2005) Long-chain fatty acid oxidation during early human development. Pediatr Res 57:755–759
Onay-Besikci A (2006) Regulation of cardiac energy metabolism in newborn. Mol Cell Biochem 287:1–11
Robert X, Gouet P (2014) Deciphering key features in protein structures with the new ENDscript server. Nucleic Acids Res 42:W320–W324
Rustin P, Chretien D, Bourgeron T et al (1994) Biochemical and molecular investigations in respiratory chain deficiencies. Clin Chim Acta 228:35–51
Schiff M, Haberberger B, Xia C et al (2015) Complex I assembly function and fatty acid oxidation enzyme activity of ACAD9 both contribute to disease severity in ACAD9 deficiency. Hum Mol Genet 24(11):3238–3247
Swigonova Z, Mohsen AW, Vockley J (2009) Acyl-CoA dehydrogenases: dynamic history of protein family evolution. J Mol Evol 69:176–193
Zhang J, Zhang W, Zou D et al (2002) Cloning and functional characterization of ACAD-9, a novel member of human acyl-CoA dehydrogenase family. Biochem Biophys Res Commun 297:1033–1042
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Additional information
Communicated by: Garry Brown
Compliance with Ethics Guidelines
Declaration of Interest
The authors report no conflicts of interest.
Synopsis
A severe ACAD9 deficiency revealed by fetal cardiomegaly with a profound complex I deficiency and a partial complex V deficiency.
Author Contributions
Jennifer Lagoutte-Renosi: data interpretation and drafting the article
Isabelle Ségalas-Milazzo: protein modeling
Marie Crahes: pathological studies
Florian Renosi: data interpretation
Laurence Menu-Bouaouiche: protein modeling
Stéphanie Torre: clinical management of the patient
Caroline Lardennois: clinical management of the patient
Marlène Rio: molecular studies
Stéphane Marret: article editing
Carole Brasse-Lagnel: analysis, data interpretation, and article editing
Annie Laquerrière: interpretation of pathological findings and article editing
Soumeya Bekri: conception and design, data interpretation, and article editing
Guarantor
Soumeya Bekri
Competing Interest Statement
The authors have no competing interests to declare.
Electronic Supplementary Material
Below is the link to the electronic supplementary material.
Rights and permissions
Copyright information
© 2015 SSIEM and Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Lagoutte-Renosi, J. et al. (2015). Lethal Neonatal Progression of Fetal Cardiomegaly Associated to ACAD9 Deficiency. In: Morava, E., Baumgartner, M., Patterson, M., Rahman, S., Zschocke, J., Peters, V. (eds) JIMD Reports, Volume 28. JIMD Reports, vol 28. Springer, Berlin, Heidelberg. https://doi.org/10.1007/8904_2015_499
Download citation
DOI: https://doi.org/10.1007/8904_2015_499
Received:
Revised:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-52846-4
Online ISBN: 978-3-662-52847-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)